权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Project 1

项目1

基本信息

批准号：
8452702
负责人：
MARTINA H WIEDAU-PAZOS
金额：
$ 18.4万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
起止时间：
2005-08-11 至
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/8452702
关键词：
Adolescent Adverse effects Affect Age Amyotrophic Lateral Sclerosis Animals Antibodies Area Axon Behavior Behavioral Biochemical Biological Biological Assay Biological Markers Biological Models Cell Culture System Cell Death Cell Extracts Cell Survival Cells Cellular Morphology Cessation of life Clinical Coculture Techniques Cohort Effect Collaborations Crystallins Detection Development Diagnostic Procedure Disease Disease Pathway Disease model Drug Targeting Electrophysiology (science)Epitopes Evaluation Event Exhibits Fluorescence Microscopy Free Radical Formation Future Genes Goals Grant Green Fluorescent Proteins Human In Vitro Investigation Knowledge Laboratories Length Link Location Measurement Measures Mediating Membrane Potentials Metals Microtubules Mitochondria Modeling Molecular Molecular Conformation Motor Motor Neurons Mouse Strains Movement Mus Nerve Degeneration Neuroglia Neurons Organelles Pathway interactions Patients Pattern Peptides Pharmaceutical Preparations Physiological Play Preparation Process Property Proteins Publishing Reporter Research Role Signal Pathway Spinal Cord Staging Staining method Stains Stem cells Synapses Synchrotrons System Techniques Testing Tetanus Helper Peptide Therapeutic Time Tissues Toxic effect Transfection Transgenes Transgenic Organisms Ubiquitin Viral Vector Work base cell type cytochrome c design human disease human embryonic stem cell improved in vivo inhibitor/antagonist mitochondrial membrane motor neuron degeneration mouse model multicatalytic endopeptidase complex mutant neuron loss overexpression oxidation prevent programs promoter protein aggregate protein aggregation relating to nervous system research study superoxide dismutase 1 synaptogenesis uptake vector

项目摘要

Aggregation and fibrillation of SODl have been implicated in disease mechanisms of Amyotrophic Lateral Sclerosis (ALS), and it is a major new goal of this Program Project renewal to develop better biological assays to study the toxicity of these multimeric forms of SODl in systems that will be more relevant to the disease in humans. In Project 2 we further develop and use a human cell culture system that closely models important cell biological aspects of motor neuron degeneration¿our recently developed human embryonic stem cell-derived motor neuron (HESC-MN) system. The cells have distinct advantages over other model systems as they represent the major cell type that degenerates in ALS and they are fully human. The cells express identifying neuronal markers, exhibit electrophysiological function typical for mature motor neurons, and can be co-cultured with other neuronal and non-neuronal cells. Transfection of these cells to express ALS-SODl proteins causes deleterious effeds on cell survival and morphology. Importantly for this project, we have recently shown that exogenously added ALS-SODl protein multimers are taken up quite well. We will utilize these cells to study the toxicity of SODl protein multimers and aggregates at different stages of their formation and relate it to the progression of motor neuron degeneration. This research plan outlines a highly collaborative, step-by-step approach to evaluate spontaneous and induced mutant and WT SODl aggregate formation in motor neurons, followed by an investigation of the consequences of SODl aggregates on neurodegenerative mechanisms and, finally, by using pharmacological inhibitors of SODl aggregation to investigate whether reduced SODl aggregation can prevent motor neuron death.

SODl的聚集和纤颤与肌萎缩侧索的发病机制有关